Journal
The New England journal of medicine
Publication Date
4-29-2021
Volume
384
Issue
17
First Page
1613
Last Page
1622
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2024947
Rights and Permissions
Friedman GK, Johnston JM, Bag AK, Bernstock JD, Li R, Aban I, Kachurak K, Nan L, Kang KD, Totsch S, Schlappi C, Martin AM, Pastakia D, McNall-Knapp R, Farouk Sait S, Khakoo Y, Karajannis MA, Woodling K, Palmer JD, Osorio DS, Leonard J, Abdelbaki MS, Madan-Swain A, Atkinson TP, Whitley RJ, Fiveash JB, Markert JM, Gillespie GY. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. N Engl J Med. 2021 Apr 29;384(17):1613-1622. Copyright © 2021 Massachusetts Medical Society doi: 10.1056/NEJMoa2024947. https://www.nejm.org/doi/10.1056/NEJMoa2024947?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Recommended Citation
Friedman, Gregory K; Abdelbaki, Mohamed S; and et al, "Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas." The New England journal of medicine. 384, 17. 1613 - 1622. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11122
Protocol
nejmoa2024947_appendix.pdf (3794 kB)
Supplementary Appendix
nejmoa2024947_disclosures.pdf (938 kB)
Disclosure Forms
nejmoa2024947_data-sharing.pdf (69 kB)
Data Sharing Statement
